Q03181 (PPARD_HUMAN) Homo sapiens (Human)

Peroxisome proliferator-activated receptor delta UniProtKBInterProSTRINGInteractive Modelling

441 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4)

Available Structures

55 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Human PPAR delta ligand binding domain in complex with a synthetic agonist TIPP401homo-2-mer170-441
100.0B7G;401;
Human peroxisome proliferator-activated receptor (PPAR) delta ligand binding domain in complex with…homo-2-mer171-441
100.0B7G;K55;
human peroxisome proliferator-activated receptor (PPAR) delta ligand binding domain in complex with…homo-2-mer171-441
100.082K;B7G;
MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORShomo-2-mer171-441
100EPA;
MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORShomo-2-mer171-441
100433;
Human PPAR delta ligand binding domain in complex with a synthetic agonist TIPP204homo-2-mer170-440
100.0B7G;K55;
Human peroxisome proliferator-activated receptor (PPAR) delta ligand binding domain in complex with…homo-2-mer172-441
100.0B7G;820;
Human peroxisome proliferator-activated receptor (PPAR) delta ligand binding domain in complex with…homo-2-mer172-441
100.0B7G;81O;
Human Peroxisome proliferator-activated receptor (PPAR) delta in complexed with a potent and select…homo-2-mer173-441
100.08RR;K;CL;PGO;JZR;
Human PPAR delta ligand binding domain in complex with a synthetic agonist H11homo-2-mer173-441
10085B;
Co-crystal structure of Inhibitor compound MA-211 in complex with human PPARdelta LBDhomo-2-mer171-439
100.01KF;
Human Nuclear Receptor-Ligand Complex 1homo-2-mer174-441
99.61B7G;VCA;
Co-crystal structure of an Inhibitor in complex with human PPARdelta LBDhomo-2-mer171-438
100.09LU;
PPARdelta complexed with an anthranilic acid partial agonisthomo-2-mer172-439
100.0IOD;DY6;
Co-crystal structure of Inhibitor compound in complex with human PPARdelta LBDhomo-2-mer172-438
100.089L;
Human PPAR delta ligand binding domain in complex with a synthetic agonist V1homo-2-mer173-439
100.0LOO;BOG;
Crystal Structure of PPAR-delta complexhomo-2-mer175-441
99.61L41;
Human PPARdelta ligand-binding domain in complexed with specific agonist 4monomer170-440
1007UY;B7G;PGO;PEG;
Human PPARdelta ligand-binding domain in complexed with specific agonist 11monomer170-440
100B7G;7SM;PGO;PEG;
Human PPARdelta ligand-binding domain in complexed with specific agonist 7monomer170-440
100.0B7G;7U1;PGO;
Crystal structure PPAR delta binding GW0742monomer171-441
100.0GW0;GOL;
Human PPARdelta ligand-binding domain in complexed with specific agonist 3monomer170-440
1007V4;B7G;PGO;PEG;K;
Human PPARdelta ligand-binding domain in complexed with specific agonist 12monomer170-439
100.07SS;PGO;PEG;B7G;
Human PPARdelta ligand-binding domain in complexed with specific agonist 2monomer170-439
100B7G;7V1;PGO;PEG;
Human PPARdelta ligand-binding domain in complexed with GW501516monomer170-439
100.0B7G;PGO;PEG;7T1;
Crystal Structure of Peroxisome Proliferator-Activated Receptor Delta (PPARd)LBD in Complex with DN…monomer171-440
100.09RF;B7G;PE3;
Crystal structure of PPAR delta complexed with GW2331monomer170-439
100.0IOD;331;B7G;
Human PPARdelta ligand-binding domain in complexed with specific agonist 1monomer173-441
100.07UJ;B7G;PGO;PEG;K;
X-ray structure of human PPAR delta ligand binding domain-pemafibrate co-crystals obtained by co-cr…monomer173-441
100.0P7F;BOG;
Human PPARdelta ligand-binding domain in complexed with specific agonist 6monomer173-441
100.0B7G;7TY;PEG;PGO;
Human PPARdelta ligand-binding domain in complexed with specific agonist 9monomer171-439
100.0B7G;7U7;PGO;PEG;
Crystal Structure of Peroxisome Proliferator-Activated Receptor Delta (PPARd) in Complex with a Ful…monomer171-439
99.24B7G;D32;
Structure of PPARdelta with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acidmonomer172-440
100.0ET1;1BO;
Structural basis for iloprost as a dual PPARalpha/delta agonistmonomer173-441
100IL2;
Human PPARdelta ligand-binding domain in complexed with specific agonist 10monomer172-439
1007UA;PGO;PEG;B7G;
Human PPARdelta ligand-binding domain in complexed with specific agonist 14monomer174-441
100.0B7G;7SY;PEG;PGO;
Human PPARdelta ligand-binding domain in complexed with specific agonist 5monomer172-439
100.07TV;PGO;PEG;B7G;
Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Act…monomer173-440
100.0WLM;1PE;
X-ray structure of human PPAR delta ligand binding domain-bezafibrate co-crystals obtained by co-cr…monomer174-440
100.0BOG;PEM;
Human PPARdelta ligand-binding domain in complexed with specific agonist 8monomer173-439
100.07U4;B7G;PGO;PEG;
PPARd complexed with a phenoxyacetic acid partial agonistmonomer173-439
100.03EQ;JZR;IOD;
X-ray structure of human PPAR delta ligand binding domain-lanifibranor co-crystals obtained by co-c…monomer174-440
100.0BJB;
3,4,5-Trisubstituted Isoxazoles as Novel PPARdelta Agonists: Part2monomer174-440
100.0GNI;
Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Act…monomer174-440
100.008S;BOG;
Human PPARdelta ligand-binding domain in complexed with specific agonist 16monomer174-439
100.07UG;PEG;PGO;
Human Nuclear Receptor-Ligand Complex 2monomer175-440
99.62CA;B7G;VCA;
MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORSmonomer175-440
99.62
X-ray structure of human PPAR delta ligand binding domain-seladelpar co-crystals obtained by co-cry…monomer174-439
100.0KKB;
PPAR Delta in complex with azppard02monomer175-440
100.03OZ;
Human PPARdelta ligand-binding domain in complexed with specific agonist 15monomer174-438
100.07UD;PEG;PGO;B7G;
Human PPARdelta ligand-binding domain in complexed with specific agonist 13monomer174-438
100.0B7G;PGO;7SV;
Human Nuclear Receptor-Ligand Complex 1monomer175-439
99.6B7G;VCA;
Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Act…monomer176-440
100.0Z00;BOG;
Ligand binding domain of PPAR delta receptor in complex with a partial agonistmonomer174-438
100.01FA;
Solution structure of the C4-type zinc finger domain from human Peroxisome proliferator-activated r…monomer72-146
100ZN;

10 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3dzy.1.Bmonomer0.7171-441
ZN;65.59
7wnh.4.Amonomer0.5774-440
ZN;27.88
7wnh.2.Amonomer0.5673-437
ZN;27.88
4nqa.1.Amonomer0.5569-438
ZN;31.27
3dzu.1.Amonomer0.5471-437
ZN;32.61
5uan.1.Amonomer0.5472-439
ZN;31.27
4iqr.2.Amonomer0.5272-439
ZN;29.75
7prw.1.Amonomer0.5269-439
ZN;21.32
4iqr.2.Bmonomer0.5272-439
ZN;29.75
7prv.1.Bmonomer0.5171-439
ZN;21.32

17 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23e00.1.Bmonomer0.6670-360
ZN;64.60
Isoform 25uan.1.Bmonomer0.5773-360
ZN;30.28
Isoform 27wnh.4.Amonomer0.5574-358
ZN;27.60
Isoform 27wnh.1.Amonomer0.5472-358
ZN;27.60
Isoform 24nqa.1.Amonomer0.5370-360
ZN;34.43
Isoform 23dzy.1.Amonomer0.5271-360
ZN;35.66
Isoform 33e00.1.Bmonomer0.7231-402
ZN;65.42
Isoform 37wnh.4.Amonomer0.5835-401
ZN;27.79
Isoform 37wnh.2.Amonomer0.5734-398
ZN;27.79
Isoform 33dzu.1.Amonomer0.5732-398
ZN;32.92
Isoform 34nqa.1.Amonomer0.5628-399
ZN;31.69
Isoform 35uan.1.Amonomer0.5533-400
ZN;31.69
Isoform 34iqr.2.Amonomer0.5333-400
ZN;29.25
Isoform 34iqr.2.Bmonomer0.5333-400
ZN;29.25
Isoform 34nqa.2.Amonomer0.5035-395
ZN;38.76
Isoform 43et2.1.Amonomer0.8374-342
ET1;1BO;100.00
Isoform 43dzy.1.Bmonomer0.7136-343
60.91